Alex Gerardo Ortega-Loayza, MD, FAAD
SESSIONS
DISCLOSURES
AbbVie – Investigator(Grants/Research Funding); Boehringer Ingelheim – Advisory Board(Honoraria), Investigator(Grants/Research Funding); Bristol Myers Squibb – Advisory Board(Honoraria); Castle Biosciences – Consultant (1099 relationship)(Fees); Clarivate – Consultant (1099 relationship)(Fees); Corvus Pharmaceuticals – Consultant (1099 relationship)(Fees); Eli Lilly – Consultant (1099 relationship)(Fees), Investigator(Grants/Research Funding); EPI-Q Inc – Consultant (1099 relationship)(Fees); Genentech – Consultant (1099 relationship)(Fees); Guidepoint Global, LLC – Consultant (1099 relationship)(Fees); Incyte – Investigator(Grants/Research Funding); InflaRx GmbH – Consultant (1099 relationship)(Fees), Investigator(Grants/Research Funding); Janssen – Investigator(Grants/Research Funding); Janssen Biotech – Advisory Board(Honoraria); Janssen Research & Development, LLC – Advisory Board(Honoraria); Otsuka Pharmaceutical Co., Ltd. – Consultant (1099 relationship)(Fees); Pfizer Inc. – Investigator(Grants/Research Funding); Sanofi – Advisory Board(Honoraria); Sitala Bio Ltd – Consultant (1099 relationship)(Fees); TFS Health Science – Consultant (1099 relationship)(Fees);